Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

INDUSTRY 6 OTHER 3 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 5 Neuroblastoma 5 Central Nervous System Neoplasms 4 Brain Neoplasms 4 Hodgkin Disease 3 Teratoma 2 Leukemia 2 Ganglioneuroblastoma 2 Astrocytoma 2 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Sertoli-Leydig Cell Tumor 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian gynandroblastoma 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Malignant mesenchymal tumor 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Granulosa cell tumor of the ovary 1

Interventions

Cisplatin 3 Taxes 2 Psychiatric Rehabilitation 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Etoposide 2 rubitecan 1 pembrolizumab 1 monalizumab 1 marimastat 1 etoposide phosphate 1 durvalumab 1 ceralasertib 1 carfilzomib 1 atezolizumab 1 Watchful Waiting 1 Sunitinib 1 Specimen Handling 1 Radiotherapy, Conformal 1 Polymerase Chain Reaction 1 Platinum Compounds 1 PM 01183 1 Nivolumab 1 NK Cell Lectin-Like Receptor Subfamily C 1 Mental Status and Dementia Tests 1 Isotretinoin 1 Irinotecan 1 Ipilimumab 1 Introns 1 Interferon-alpha 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Small Cell Lung Carcinoma × etoposide phosphate × Clear all

NCT02580994 2023-12-11

REACTION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡